Medison Pharma Announces Multi-Regional Partnership Agreement ... - 06 June 2022 21:00

PETACH TIKVAH, Israel, June 6, 2022 /PRNewswire-AsiaNet/ -- Medison Pharma [http://www.medisonpharma.com/] ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today an exclusive multi-regional agreement with argenx ...

  CStone and Pfizer announce NMPA approval of sugemalimab in pat... - 06 June 2022 15:55

SUZHOU, China, June 6, 2022 /PRNewswire-AsiaNet/ -- * The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiot...

  Vazyme Releases 2021 Annual Report: Announces More Efforts in ... - 02 June 2022 15:34

NANJING, China, June 2, 2022 /PRNewswire-AsiaNet/-- Vazyme, China's leading biotechnology company, has recently released its 2021 annual report, revealing that the company has maintained a steady and solid growth throughout the past year. The report shows that it has achieved $289 million in operat...

  Cambrex Acquires Leading EU Stability Storage Company Q1 Scien... - 01 June 2022 21:00

EAST RUTHERFORD, NJ, June 1, 2022, /PRNewswire-AsiaNet/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced the acquisition of Q1 Scientific – a leading pro...

  PMB Announces EIT Health Supported FLASHKNiFE Consortium Towar... - 01 June 2022 18:15

PEYNIER, France, June 1, 2022 /PRNewswire-AsiaNet/ -- PMB announces the launch of the FLASHKNiFE Consortium, supported by the European Institute of Innovation & Technology for Health (EIT Health). This European public-private partnership aims at advancing radiation therapy by introducing a new radiot...

  Tau-targeting Alzheimer's treatment, HMTM, moving toward regul... - 01 June 2022 18:00

SINGAPORE, June 1, 2022 /PRNewswire-AsiaNet/ -- - LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer's based on published research - Safety profile is favourable and consistent with previous HM...

  Winner Medical Announces to Acquire 55% Stake in Zhejiang Long... - 31 May 2022 14:12

SHENZHEN, China, May 31, 2022 /PRNewswire-AsiaNet/ -- On April 10 Winner Medical announced that it has signed a definitive agreement to acquire 55% stake in Zhejiang Longterm Medical Technology Co., Ltd. for US $108.2 million. Winner Medical believes that the acquisition aligns with the company's ...

  MedAlliance's SELUTION SLR Drug-Eluting Balloon (DEB) Receives... - 30 May 2022 09:00

GENEVA, May 30, 2022 /PRNewswire-AsiaNet/-- The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted "breakthro...

  Menarini inaugurates new regional headquarters in Dubai, UAE - 27 May 2022 00:34

DUBAI, UAE, May 26, 2022 /PRNewswire-AsiaNet/ -- The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough research Menarini, the leading Italian pharma...

  Pierre Fabre and EORTC open a large Phase III clinical study i... - 25 May 2022 16:15

CASTRES, France and BRUSSELS, May 24, 2022 /PRNewswire-AsiaNet/ -- - First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma - A global partnership between EORTC and Pierre Fabre to advance research in melanoma ...